Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...
Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...
Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories ...
Investigators found negative mental health conditions among women firefighters may reduce levels of key hormone associated with ovarian reserve.
Discover the difference between burnout vs depression, including causes, symptoms, and how both are treated, according to ...
Teens dealing with stress tend to struggle as they enter the labor force as young adults, which can affect their pay, according to a study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback